An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 05mm thick at diagnosis
Authors:
- 1 August 2008
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 159 (2) , 337-341
Abstract
Despite current guidelines, there is uncertainty about the required duration and frequency of follow-up visits for patients with invasive primary cutaneous melanoma < 0.5 mm thick. To review patients with invasive melanoma thinner than 0.5 mm followed for at least 5 years to provide an evidence base for considering modification of guidelines. A retrospective review of 430 patients diagnosed in the west of Scotland during 1992-2001 with melanoma < 0.5 mm was carried out. Recurrence, deaths from melanoma and second primary melanomas were all identified. From 1992 to 2001, 430 melanomas < 0.5 mm thick at diagnosis were diagnosed out of a total of 3036 primary cutaneous melanomas. To date there have been 593 deaths from melanoma (19%) in the whole group. Five of these deaths were reported in patients with melanomas < 0.5 mm, but on pathological review two were thicker than 0.5 mm at diagnosis (1.5 and > 3 mm), and the remaining three patients all developed thicker second primary melanomas (2.7, 12.0 and 19.0 mm) with a recurrence pattern and timing indicating that these thicker primaries were the cause of death. Fourteen further patients developed a second primary melanoma, and 13 are currently alive and disease free, one dying of other causes. Our data indicate that recurrence and subsequent death from melanomas < 0.5 mm is a very rare event, and that quarterly follow-up for 3 years will yield very few events. Modification of current guideline recommendations are suggested to include a period of patient education concentrating on recognition of second primary tumours followed by rapid access to an expert opinion if required.Keywords
This publication has 13 references indexed in Scilit:
- Melanoma incidence and mortality in Scotland 1979–2003British Journal of Cancer, 2007
- Follow-up in patients with localised primary cutaneous melanomaThe Lancet Oncology, 2005
- Predictions of skin cancer incidence in the Netherlands up to 2015British Journal of Dermatology, 2005
- Cutaneous malignant melanoma in EuropeEuropean Journal of Cancer, 2004
- The future incidence of cutaneous melanoma within the U.K.British Journal of Dermatology, 2004
- U.K. guidelines for the management of cutaneous melanomaBritish Journal of Dermatology, 2002
- Predicting five-year outcome for patients with cutaneous melanoma in a population-based studyCancer, 1996
- Risk of Melanoma and Other Cancers in Melanoma-Prone FamiliesJournal of Investigative Dermatology, 1993
- A study of thin (< 1.5 mm) malignant melanomas with poor prognosisBritish Journal of Plastic Surgery, 1993
- Cutaneous malignant melanoma, Scotland, 1979-89The Lancet, 1992